Add-on Acquisition • Life Science

MLM Medical Labs Acquires CirQuest Labs

On July 9, 2020, MLM Medical Labs acquired life science company CirQuest Labs

Acquisition Context

This is MLM Medical Labs’ 1st transaction in the Life Science sector.
This is MLM Medical Labs’ 1st transaction in the United States.
This is MLM Medical Labs’ 1st transaction in Tennessee.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	July 9, 2020
Target	CirQuest Labs
Sector	Life Science
Buyer(s)	MLM Medical Labs
Deal Type	Add-on Acquisition

Target Company

CirQuest Labs

Memphis, Tennessee, United States

CirQuest Labs provides the highest standards of life science services to the pharmaceutical and implantable device industries. CirQuest provides specialized assay development, biomarker testing, and central lab services to its global client base of leading pharmaceutical and life sciences companies.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

MLM Medical Labs

Mönchengladbach, Germany

Category	Company
Founded	1993
Sector	Life Science

DESCRIPTION

MLM Medical Labs offers a full range of laboratory services, including specialized biomarker testing, clinical chemistry, standard safety profiles, and analyses of drug compounds, metabolites and molecular diagnostic parameters. MLM Medical Labs was founded in 1993 and is headquartered in Moenchengladbach, Germany.

Deal Context for Buyer	#
Overall	1 of 2
Sector: Life Science	1 of 2
Type: Add-on Acquisition	1 of 2
State: Tennessee	1 of 1
Country: United States	1 of 2
Year: 2020	1 of 2

FOLLOWING DEAL

DATE	TARGET	DEAL TYPE	VALUE
2020-10-27	MD Biosciences Oakdale, Minnesota, United States MD Biosciences, Inc. is a provider of preclinical, translational, and clinical-phase contract research services for the development of pharmaceutical and diagnostic assets. MD Biosciences was established in 1991 and is based in Oakdale, Minnesota.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2020-10-27

MD Biosciences

Oakdale, Minnesota, United States

MD Biosciences, Inc. is a provider of preclinical, translational, and clinical-phase contract research services for the development of pharmaceutical and diagnostic assets. MD Biosciences was established in 1991 and is based in Oakdale, Minnesota.

Buy

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Tennessee M&A - United States M&A - 2020 M&A